These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 8024164

  • 21. Intermittent claudication: a double-blind crossover trial of pentoxifylline.
    Gallus AS, Gleadow F, Dupont P, Walsh J, Morley AA, Wenzel A, Alderman M, Chivers D.
    Aust N Z J Med; 1985 Aug; 15(4):402-9. PubMed ID: 3866536
    [Abstract] [Full Text] [Related]

  • 22. Effects of flunarizine and pentoxifylline on walking distance and blood rheology in claudication.
    Perhoniemi V, Salmenkivi K, Sundberg S, Johnsson R, Gordin A.
    Angiology; 1984 Jun; 35(6):366-72. PubMed ID: 6375469
    [Abstract] [Full Text] [Related]

  • 23. [Comparison of the effectiveness of intra-arterial and intravenous administration of buflomedil in patients with intermittent claudication].
    Diehm C, Eckstein M, Hübsch-Müller C.
    Vasa; 1989 Jun; 18(1):40-7. PubMed ID: 2648691
    [Abstract] [Full Text] [Related]

  • 24. The effect of withdrawal of drugs treating intermittent claudication.
    Dawson DL, DeMaioribus CA, Hagino RT, Light JT, Bradley DV, Britt KE, Charles BE.
    Am J Surg; 1999 Aug; 178(2):141-6. PubMed ID: 10487267
    [Abstract] [Full Text] [Related]

  • 25. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
    Hood SC, Moher D, Barber GG.
    CMAJ; 1996 Oct 15; 155(8):1053-9. PubMed ID: 8873633
    [Abstract] [Full Text] [Related]

  • 26. Buflomedil for intermittent claudication.
    de Backer TL, Bogaert M, Vander Stichele R.
    Cochrane Database Syst Rev; 2007 Oct 17; (4):CD000988. PubMed ID: 17943749
    [Abstract] [Full Text] [Related]

  • 27. Double-blind placebo-controlled trial of buflomedil in intermittent claudication.
    Fonseca V, Mikhailidis DP, Barradas MA, Jeremy JY, Gracey L, Dandona P.
    Int J Clin Pharmacol Res; 1988 Oct 17; 8(5):377-81. PubMed ID: 3229875
    [Abstract] [Full Text] [Related]

  • 28. Acenocoumarol and pentoxifylline in intermittent claudication. A controlled clinical study. The APIC Study Group.
    Dettori AG, Pini M, Moratti A, Paolicelli M, Basevi P, Quintavalla R, Manotti C, Di Lecce C.
    Angiology; 1989 Apr 17; 40(4 Pt 1):237-48. PubMed ID: 2650578
    [Abstract] [Full Text] [Related]

  • 29. Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication.
    Lee TM, Su SF, Tsai CH, Lee YT, Wang SS.
    Clin Sci (Lond); 2001 Sep 17; 101(3):305-11. PubMed ID: 11524048
    [Abstract] [Full Text] [Related]

  • 30. Pentoxifylline--a new drug for the treatment of intermittent claudication.
    Chopra HK, Chopra KL, Aggarwal KK, Parashar SK.
    Indian Heart J; 1989 Sep 17; 41(2):127-33. PubMed ID: 2744799
    [Abstract] [Full Text] [Related]

  • 31. Clinical and microcirculatory effects of transcutaneous CO2 therapy in intermittent claudication. Randomized double-blind clinical trial with a parallel design.
    Fabry R, Monnet P, Schmidt J, Lusson JR, Carpentier PH, Baguet JC, Dubray C.
    Vasa; 2009 Aug 17; 38(3):213-24. PubMed ID: 19736632
    [Abstract] [Full Text] [Related]

  • 32. Intermittent claudication in diabetics: treatment with exercise and pentoxifylline--a 6-month, controlled, randomized trial.
    Belcaro G, Nicolaides AN, Griffin M, De Sanctis MT, Cesarone MR, Incandela L, Ippolito E, Pomante P, Geroulakos G, Ramaswami G.
    Angiology; 2002 Aug 17; 53 Suppl 1():S39-43. PubMed ID: 11865835
    [Abstract] [Full Text] [Related]

  • 33. A meta-analysis of randomized, double-blind, placebo-controlled studies of the effect of buflomedil on intermittent claudication.
    Walker GA, Mac Hannaford JC.
    Fundam Clin Pharmacol; 1995 Aug 17; 9(4):387-94. PubMed ID: 8566940
    [Abstract] [Full Text] [Related]

  • 34. Peripheral vasodilators versus pentoxifylline for the treatment of intermittent claudication.
    Aviado DM.
    Ric Clin Lab; 1983 Aug 17; 13 Suppl 3():263-8. PubMed ID: 6143383
    [Abstract] [Full Text] [Related]

  • 35. Buflomedil for intermittent claudication.
    de Backer TL, Bogaert M, Vander Stichele R.
    Cochrane Database Syst Rev; 2008 Jan 23; (1):CD000988. PubMed ID: 18253982
    [Abstract] [Full Text] [Related]

  • 36. Intravenous treatment of chronic peripheral occlusive arterial disease: a double-blind, placebo-controlled, randomized, multicenter trial of pentoxifylline.
    Rudofsky G, Haussler KF, Künkel HP, Schneider-May H, Spengel F, Symann O, Werner HJ.
    Angiology; 1989 Jul 23; 40(7):639-49. PubMed ID: 2662830
    [Abstract] [Full Text] [Related]

  • 37. Comparative evaluation of the effectiveness of buflomedil and pentoxifylline in patients with arterial occlusive disease.
    Trübestein G, Trübestein R, Duong QD.
    Angiology; 1981 Oct 23; 32(10):705-10. PubMed ID: 7034591
    [Abstract] [Full Text] [Related]

  • 38. Buflomedil for intermittent claudication.
    de Backer TL, Vander Stichele R.
    Cochrane Database Syst Rev; 2013 Mar 28; 2013(3):CD000988. PubMed ID: 23543509
    [Abstract] [Full Text] [Related]

  • 39. Current therapy of peripheral obstructive arterial disease. The non-surgical approach.
    De Felice M, Gallo P, Masotti G.
    Angiology; 1990 Jan 28; 41(1):1-11. PubMed ID: 2407152
    [Abstract] [Full Text] [Related]

  • 40. The pentoxifylline experience: exercise testing reconsidered.
    Lindgärde F, Labs KH, Rössner M.
    Vasc Med; 1996 Jan 28; 1(2):145-54. PubMed ID: 9546930
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.